Learn about the groundbreaking cardiovascular care offered at the Mount Sinai Health System. Ranked by U.S. News & World Report as No. 6 in the nation for Cardiology and Heart Surgery, Mount Sinai Heart at The Mount Sinai Hospital is recognized internationally as a leader in advancing all aspects of cardiology care, cardiac surgery, and cardiovascular research. Under the leadership of Valentín Fuster, MD, PhD, our team of award-winning physicians is expanding the field of knowledge in cardiovascular medicine, including treatments for arrhythmias, coronary artery disease, heart failure, valvular disease, and vascular disease.
Referring a patient is easy. Just click the “Refer a Patient Online” button.
Learn about the groundbreaking cardiovascular care offered at the Mount Sinai Health System. Ranked by U.S. News & World Report as No. 6 in the nation for Cardiology and Heart Surgery, Mount Sinai Heart at The Mount Sinai Hospital is recognized internationally as a leader in advancing all aspects of cardiology care, cardiac surgery, and cardiovascular research. Under the leadership of Valentín Fuster, MD, PhD, our team of award-winning physicians is expanding the field of knowledge in cardiovascular medicine, including treatments for arrhythmias, coronary artery disease, heart failure, valvular disease, and vascular disease.
Referring a patient is easy. Just click the “Refer a Patient Online” button.
Cardiology Content
Implementing school-based programs aimed at teaching healthy cardiovascular health habits as early as preschool can achieve lasting lifestyle changes in children, according to a review published today in the Journal of the American College of Cardiology.
Mount Sinai Heart Specialty Report 2022
This year, The Mount Sinai Hospital was ranked among the top 6 in the nation for cardiology and cardiac surgery, according to U.S. News & World Report, and ranked No. 4 in the world by Newsweek.
Mount Sinai Heart leader was recognized for his exceptional achievements at the 71st annual ACC conference.
All physicians will receive their awards during a convocation ceremony on April 4.
Chronic thrombocytopenia was not associated with a higher risk of NACE or major bleeding after TAVR
The study evaluates the treatment effects of ticagrelor monotherapy in patients with an increasing number of high-risk criteria
ACC Cardiology Hour From ACC.21 With Dr. Valentín Fuster
Valentín Fuster, MD, PhD, Director of Mount Sinai Heart, Physician-in-Chief of The Mount Sinai Hospital in New York, and Editor-in-Chief of JACC, hosts the annual Cardiology Hour and includes commentary on multiple late-breaking clinical ...
Direct Reprogramming Induces Vascular Regeneration Post Muscle Ischemic Injury
Using direct reprogramming with modified mRNA to induce vascular regeneration in a mouse model of ischemic muscle injury
Thailand’s “Prince Mahidol Award” recognizes Valentín Fuster, MD, PhD for his exemplary work in cardiovascular health and disease
Mount Sinai leads international anticoagulation trial for answers on preventing clots in mild hospitalization cases
A Heart to Heart from the Women of Mount Sinai Heart
Join our Mount Sinai Health System Heart leaders as we recognize American Heart Association’s National Go Red Day
CAD was not associated with a higher risk of NACE or major bleeding at 30 days after TAVR
Adult Congenital Heart Disease: Where We Are Today
Watch Ali N. Zaidi, MD, provide an overview of the history and current state of adult congenital heart disease in this Grand Rounds conference
Valentin Fuster, MD, PhD: Improving Heart Health, Starting with Children
Valentin Fuster, MD, PhD: Improving Heart Health, Starting with Children
Study outlines better way to identify where stents are necessary
A new, updated risk score can help predict possible contrast-associated acute kidney injury (CA-AKI) among patients undergoing percutaneous coronary intervention (PCI), Mount Sinai researchers report.
Roxana Mehran, MD: driving force in women's cardiovascular health
As the Endowed Chair of Cardiovascular Research and Outcomes at the Icahn School of Medicine at Mount Sinai, Roxana Mehran, MD, is the lead Commissioner of the Lancet women and cardiovascular disease Commission
Scientists Show How AI May Spot Unseen Signs of Heart Failure
Mount Sinai study suggests a new self-learning algorithm may detect blood pumping problems by reading electrocardiograms
COVID-19: Thrombotic Complications and Therapy
Our panel of Mount Sinai experts discuss effective patient evaluation, management, and antithrombotic strategies for COVID-19
Samin K. Sharma, MD, discusses atherectomy
Listen to Dr. Sharma as he discusses the success rate of atherectomies at Mount Sinai Hospital’s Cardiac Catheterization Lab.
Beyond Ischemia Trial: Case Studies and Management of CAD
Gregg Stone, MD, FACC, FSCAI, leads a discussion of four case studies in light of the findings of the landmark ISCHEMIA trial.
Explanation for Reduced MI During COVID-19 Pandemic
Samin K. Sharma, MD, discusses whether acute vascular illnesses are reduced or under-reported during COVID-19.
COVID-19 Pandemic: Opportunities Lost and Lessons Learned, Part III
A cross-disciplinary panel discusses the effect COVID-19 has on organs throughout the body, and lessons learned during the outbreak in New York.
ACC Cardiology Hour at ACC.20/WCC Virtual with Valentín Fuster, MD, PhD, MACC
ACC Cardiology Hour at ACC.20/WCC Virtual with Valentín Fuster, MD, PhD, MACC
Important Vascular Medicine Concepts for the Cardiologist
An illustration of diagnostic inquiry with three case presentations.
COVID-19: Antibodies and Vaccine
An overview of the current approaches to vaccine development for COVID-19
Challenging Electrophysiology Cases During COVID-19
Watch two case presentations and an overview of research on COVID-19 and electrophysiology.
Valentín Fuster, MD, PhD, offers calming advice for heart patients, as well as guidelines for preventing and seeking care for COVID-19.
Dr. Lala-Trindade presents Ground Rounds about congestive heart failure
Decongesting congestive heart failure
The Mount Sinai Hospital Included in New Ranking of Best Specialized Hospitals from Newsweek
Gastroenterology and Mount Sinai Heart are among the specialties recognized at The Mount Sinai Hospital in Newsweek’s “The World’s Best Specialized Hospitals 2021.”
Discover Helpful Cardiology Apps
Learn cardiovascular techniques and concepts on your favorite device.
Each week, Valentin Fuster, MD, PhD, MACC, renowned editor-in-chief of the Journal of the American College of Cardiology (JACC), records a free podcast highlighting journal findings.
Conducting high quality research: top cardiologists and journal editors in conversation
Dr. Dong Zhao questions her distinguished panel of experts and editors as they discuss essential qualities in pursuing clinical research for cardiologists, both in the US and China, as well as identifying good research topics and research practices.
The Efficacy of Blood Thinners for COVID-19 and Best Potential Regimens
Mount Sinai researchers provide additional data on the efficacy of anticoagulants and insight into the best potential regimens.
A pioneering program to promote lifelong cardiovascular health in children starting in kindergarten is being expanded by Mount Sinai Heart to schools across the five boroughs of New York City following a successful pilot in spring 2021.
Mount Sinai Team Pioneers a Multidisciplinary Treatment of Mitral Valve Prolapse
A team at Mount Sinai Heart has developed a novel approach integrating open-heart cryoablation and mitral valve repair during one operation.
The Food and Drug Administration (FDA) in February 2021 approved evinacumab as an add-on treatment for patients aged 12 years and older with homozygous familial hypercholesterolemia (HoFH), a genetic condition that causes severely high cholesterol.
Mount Sinai Adult Congenital Heart Disease Center Earns Accreditation as a Comprehensive Care Center
In recognition of its expertise in treating adults with congenital heart disease (ACHD), the Mount Sinai Adult Congenital Heart Disease Center has been accredited by the Adult Congenital Heart Association (ACHA) as a Comprehensive Care Center.
In this downloadable PDF, Healio summarizes an article from the Journal of the American College of Cardiology, which reviews the current global landscape for cardiovascular disease and its risk factors.
Mount Sinai Heart Specialty Report 2021
Message From Valentin Fuster, MD, PhD, Director of Mount Sinai Heart
Cardiovascular Surgery Content
Patients with chronic kidney disease (CKD) are more likely to sustain adverse cardiac events following percutaneous coronary intervention (PCI).
The Ross Procedure Leads to Improved Survival in Adults Undergoing Aortic Valve Surgery
Study shows better outcomes and fewer complications compared to mechanical or biological aortic valve replacement
Patient Liba’s Case: Mount Sinai Repairs Two Heart Valves in One Procedure
A Mount Sinai surgery team was able to repair both the child's aortic and mitral valves during the same operation.
Mount Sinai study is first to compare this anticoagulant with the standard of care in large randomized clinical trial
David Adams, MD, introduces Prosthetic Heart Valve Replacement presentation
Dr. Adams presents Dr. Anyanwu, who explores the options and tradeoffs in aortic valve replacement, and the issues that should be discussed between doctor and patient.
Mount Sinai Launches Mobile App to Optimize Care for Heart Attack Patients
Unique technology enhances outcomes during life-threatening emergencies
Bicuspid Aortic Valve Patients: What Are Your Options?
Mount Sinai aortic valve specialists discuss bicuspid aortic valves, the issues they may present, and options for patients
Aortic Valve Surgery in Non-Elderly Adults: What's New?
Join Ismail El-Hamamsy, MD, PhD, as he discusses the latest in aortic valve surgery in non-elderly adults, and reviews what is new in the literature on this topic
The Ross Procedure: Step-by-Step Technique to Optimize Long-term Durability
Presented by Ismail El-Hamamsy, MD, PhD, this Department of Cardiovascular Surgery Grand Rounds lecture covers the surgical steps of the Ross Procedure
A novel device called venous external support (VEST) may lead to increased longevity and durability of saphenous (leg) vein grafting during coronary artery bypass surgery, according to a new trial done in collaboration with Mount Sinai ...
Vacuum-assisted debulking (VD) of large vegetations as an adjunct to percutaneous lead extraction provides an opportunity to mitigate the risks of massive embolism that may occur with percutaneous lead removal.
Patients with life-threatening pulmonary emboli (PE) have traditionally been treated with anticoagulation alone, yet emerging data suggest that more aggressive therapy may improve short-term outcomes.
Lessons learned on a new procedure: Nonsternotomy minimally invasive pulmonary embolectomy
The endpoint in emergent management of acute massive pulmonary embolism (PE) has traditionally been with embolectomy through a standard median sternotomy.
Renowned Cardiovascular Immunology Researcher Leads New Cardiovascular Research Institute
Filip Swirski, PhD, an internationally recognized leader in cardiovascular immunology research, is the inaugural Director of the new Cardiovascular Research Institute.
Use of Novel Technique to Measure Artery Blockages Leads to Improved Outcomes After PCI
Use of a novel technique called the quantitative flow ratio (QFR) to precisely identify and measure the severity of artery blockages can lead to significantly improved outcomes after percutaneous coronary intervention (PCI), according ...
Study of Single-Chamber Leadless Pacemaker Sets Stage for Two-Chamber System
A study showing the safety and effectiveness of a leadless cardiac pacemaker for right ventricular pacing has set the stage for research into a novel dual-chamber device that would serve a significantly broader population of patients with ...
Risk Score to Help Predict Possible Contrast-Associated Kidney Injury After PCI
An updated risk score can help predict possible contrast-associated acute kidney injury (CA-AKI) among patients undergoing percutaneous coronary intervention (PCI), according to Mount Sinai Heart researchers, led by Roxana Mehran, MD, ...
Outline Provides Guidance for Management of Heart Failure Patients During COVID-19 Pandemic
A scientific statement outlining unique considerations and suggestions for managing heart failure patients during the COVID-19 pandemic was issued in September 2021 by the Heart Failure Society of America, and Anuradha Lala, MD, Assistant ...
Ross Procedure Leads to Improved Survival in Adults Undergoing Aortic Valve Surgery
The Ross procedure may be a more favorable option for aortic valve replacement among patients under 50 years old than more standard mechanical or biological replacements, according to a study from Mount Sinai Heart.
Surgical “VEST” Device Shows Potential in Coronary Bypass Grafting Using Leg Veins
A novel device called venous external support (VEST) may lead to increased longevity and durability of saphenous (leg) vein grafting during coronary artery bypass surgery, according to a multicenter trial coordinated by the Icahn School ...
Outcomes Following Shock Aortic Valve Replacement: Transcatheter Versus Surgical Approaches
Comparing transcatheter aortic valve replacement (TAVR) with surgical aortic valve replacement (SAVR) for patients in shock, despite a higher risk TAVR group, patients in shock undergoing either TAVR or SAVR have similar 30-day mortality. ...
Outcomes of convergent atrial fibrillation ablation with continuous rhythm monitoring
Outcomes of catheter ablation for persistent atrial fibrillation (PeAF) are suboptimal. The convergent procedure (CP) offers improved efficacy by combining endocardial and epicardial ablation.
Vacuum-assisted extraction of ilio-caval and right heart masses: A 5-year single center experience
Despite paucity of data, there exists growing popularity of catheter-based extraction methods for intravascular thrombi and vegetations.
Effects and outcomes of cardiac surgery in patients with cardiometabolic syndrome
Cardiometabolic syndrome (CMS) is diabetes mellitus (or insulin resistance) plus any two of the following risk factors: hypertension, obesity, and hyperlipidemia.
The incidence and outcomes of patients with heparin-induced thrombocytopenia (HIT) are well defined for general cardiac surgical populations.